Cargando…
Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity
OBJECTIVE: To evaluate the prostate cancer therapy efficiency of the synergistic combination docetaxel (DTX) and formononetin (FMN) in one nano-sized drug delivery system. Hyaluronic acid (HA) and epidermal growth factor receptor-targeted peptide (GE11) dual ligands were applied to modify the nano-s...
Autores principales: | Dong, Zhaoqiang, Wang, Yuzhen, Guo, Jing, Tian, Chuan, Pan, Wengu, Wang, Hongwei, Yan, Jieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380734/ https://www.ncbi.nlm.nih.gov/pubmed/35983428 http://dx.doi.org/10.2147/DDDT.S366622 |
Ejemplares similares
-
Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti myocardial infarction activity assessment
por: Yan, Jieke, et al.
Publicado: (2022) -
Formononetin: A Pathway to Protect Neurons
por: Ma, Xiaoyu, et al.
Publicado: (2022) -
An Alternative Pathway for Formononetin Biosynthesis in Pueraria lobata
por: Li, Jia, et al.
Publicado: (2016) -
Parent-Metabolite Pharmacokinetic Modeling of Formononetin and Its Active Metabolites in Rats after Oral Administration of Formononetin Formulations
por: Kim, Ju Hee, et al.
Publicado: (2022) -
Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials
por: Tian, Jiao, et al.
Publicado: (2022)